AUPR726201A0 - New use of a cyclic compound - Google Patents
New use of a cyclic compoundInfo
- Publication number
- AUPR726201A0 AUPR726201A0 AUPR7262A AUPR726201A AUPR726201A0 AU PR726201 A0 AUPR726201 A0 AU PR726201A0 AU PR7262 A AUPR7262 A AU PR7262A AU PR726201 A AUPR726201 A AU PR726201A AU PR726201 A0 AUPR726201 A0 AU PR726201A0
- Authority
- AU
- Australia
- Prior art keywords
- cyclic compound
- new use
- new
- cyclic
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D281/02—Seven-membered rings
- C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D281/06—Seven-membered rings having the hetero atoms in positions 1 and 4 not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPR7262A AUPR726201A0 (en) | 2001-08-24 | 2001-08-24 | New use of a cyclic compound |
PCT/JP2002/008443 WO2003018019A2 (en) | 2001-08-24 | 2002-08-21 | New use of cyclic compounds |
AU2002313591A AU2002313591A1 (en) | 2001-08-24 | 2002-08-21 | New use of cyclic compounds |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPR7262A AUPR726201A0 (en) | 2001-08-24 | 2001-08-24 | New use of a cyclic compound |
Publications (1)
Publication Number | Publication Date |
---|---|
AUPR726201A0 true AUPR726201A0 (en) | 2001-09-20 |
Family
ID=3831215
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AUPR7262A Abandoned AUPR726201A0 (en) | 2001-08-24 | 2001-08-24 | New use of a cyclic compound |
Country Status (2)
Country | Link |
---|---|
AU (1) | AUPR726201A0 (en) |
WO (1) | WO2003018019A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104926707B (en) * | 2015-05-12 | 2017-10-27 | 江苏福瑞生物医药有限公司 | A kind of synthetic method of pharmaceutical intermediate |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL134816A (en) * | 1995-12-08 | 2003-02-12 | Agouron Pharma | Substituted diarylether sulfonic acids and their preparation |
PL331900A1 (en) * | 1996-08-28 | 1999-08-16 | Procter & Gamble | 1,4-heterocyclic inhibitors of metaloprotease |
US6333324B1 (en) * | 1996-12-17 | 2001-12-25 | Fujisawa Pharmaceutical Co., Ltd. | Piperazine compounds as inhibitors of MMP or TNF |
YU37499A (en) * | 1997-02-11 | 2002-09-19 | Pfizer Inc. | Arylsulfonyl hydroxamic acid derivatives |
CA2340182A1 (en) * | 1998-08-12 | 2000-02-24 | Pfizer Products Inc. | Tace inhibitors |
AR035313A1 (en) * | 1999-01-27 | 2004-05-12 | Wyeth Corp | ACETILENIC TACE INHIBITORS OF HYDROXAMIC ACID OF SULFONAMIDE BASED ON ALFA-AMINO ACIDS, PHARMACEUTICAL COMPOSITIONS AND THE USE OF THE SAME FOR THE MANUFACTURE OF MEDICINES. |
EP1081137A1 (en) * | 1999-08-12 | 2001-03-07 | Pfizer Products Inc. | Selective inhibitors of aggrecanase in osteoarthritis treatment |
WO2002067866A2 (en) * | 2001-02-27 | 2002-09-06 | Axys Pharmaceuticals, Inc. | Piperazine derivatives as metalloprotease inhibitors |
-
2001
- 2001-08-24 AU AUPR7262A patent/AUPR726201A0/en not_active Abandoned
-
2002
- 2002-08-21 WO PCT/JP2002/008443 patent/WO2003018019A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2003018019A3 (en) | 2003-12-04 |
WO2003018019A2 (en) | 2003-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003275828A1 (en) | Stator of a moineau-pump | |
AU2001241142A1 (en) | Cyclic compounds | |
AUPR516901A0 (en) | Improvements to a single use syringe | |
AU2002360487A1 (en) | Acyclovir-peptide analogs | |
AU2002361149A1 (en) | Set of teeth | |
AU2002359165A1 (en) | Novel compounds | |
AUPR878201A0 (en) | New compounds | |
AUPR362001A0 (en) | New compound | |
AU2002328576A1 (en) | Cyclic amine compound | |
AU2002351523A1 (en) | Monitoring of a reservoir | |
AUPR409401A0 (en) | Analgesic compound | |
AU2002361117A1 (en) | 5-membered cyclic compounds | |
AUPR755501A0 (en) | Cyclic compound | |
AUPR726201A0 (en) | New use of a cyclic compound | |
AUPR960001A0 (en) | A syringe | |
AU2002359317A1 (en) | Methods of using 48149, a human aminopeptidase family member | |
AU2002313591A1 (en) | New use of cyclic compounds | |
AUPR336401A0 (en) | New compound | |
AUPR336301A0 (en) | New compound | |
AU2002357226A1 (en) | The total synthesis of merrilactone a | |
AUPQ575100A0 (en) | Cyclic compound | |
AUPQ860300A0 (en) | Cyclic compound | |
AU2002250542A1 (en) | Novel guanidino compounds | |
AU2002255414A1 (en) | New compounds | |
AUPR300701A0 (en) | New compounds |